MITRAL VALVE PROLAPSE AND SUDDEN CARDIAC DEATH: WHO IS IN THE RISK GROUP?
Mitral valve prolapse (MVP) is a congenital heart disease, fairly widespread in the population (2-8%). It rarely has complications, but they are serious and include sudden cardiac death (SCD), risk of which rises twofold from 0.2-0.4% cases by MVP. Most deaths are observed among young healthy women....
Main Authors: | O. E. Shirobokikh, N. A. Bylova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2016-06-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/529 |
Similar Items
-
The specifics of adhesion function of endothelium in various clinical variants of primary mitral valve prolapse
by: A. V. Yagoda, et al.
Published: (2016-02-01) -
Clinical and functional features of mitral valve prolapse in adolescents
by: S. M. Kushnir, et al.
Published: (1970-01-01) -
Mitral valve prolapse in young athletes
by: A. S. Sharykin, et al.
Published: (2016-03-01) -
Long-term magnesium orotate therapy in patients with mitral valve prolapse
by: A. I. Martynov, et al.
Published: (2012-06-01) -
MODERN METHODS OF MITRAL VALVE PROLAPSE DIAGNOSTICS AND PREVALENCE ASSESSMENT IN YOUNG PEOPLE
by: E. G. Malev, et al.
Published: (2010-02-01)